Chen S C, Paul M L, Gilbert G L
Department of Clinical Microbiology, Westmead Hospital, NSW.
Pathology. 1993 Apr;25(2):180-3. doi: 10.3109/00313029309084795.
Thirty-five clinical isolates of Legionella species were tested against 7 antimicrobial agents using an agar dilution technique. Results obtained on charcoal-supplemented (BCYE) and charcoal-free agar (BSYE) were compared. On BCYE, the most active agent was rifampicin; the minimal inhibitory concentration inhibiting 90% of the strains (MIC90) was 0.008 mg/L. Imipenem was the next most active in vitro (MIC90 0.06 mg/L). The macrolide antibiotics and ciprofloxacin also inhibited the organisms at low concentrations (MIC90 < or = 2 mg/L). In general, MIC's obtained on BCYE agar were at least twofold higher than on BSYE agar except for that of imipenem. BSYE agar is a suitable alternative medium for susceptibility testing of most Legionella species. Erythromycin and rifampicin continue to demonstrate good in vitro activity against legionellae in Australia. On the basis of in vitro susceptibility tests, the other macrolides and ciprofloxacin are likely to be suitable alternatives for the treatment of legionellosis.
采用琼脂稀释技术,对35株军团菌临床分离株进行了7种抗菌药物的测试。比较了在添加木炭的(BCYE)和无木炭的琼脂(BSYE)上获得的结果。在BCYE上,最具活性的药物是利福平;抑制90%菌株的最低抑菌浓度(MIC90)为0.008mg/L。亚胺培南是体外活性次之的药物(MIC90为0.06mg/L)。大环内酯类抗生素和环丙沙星也能在低浓度下抑制这些微生物(MIC90≤2mg/L)。一般来说,除亚胺培南外,在BCYE琼脂上获得的MIC至少比在BSYE琼脂上高两倍。BSYE琼脂是大多数军团菌属药敏试验的合适替代培养基。在澳大利亚,红霉素和利福平对军团菌仍显示出良好的体外活性。根据体外药敏试验结果,其他大环内酯类药物和环丙沙星可能是治疗军团菌病的合适替代药物。